Systematic Review of Tobacco Use after Lung or Head/Neck Cancer Diagnosis: Results and Recommendations for Future Research.
Tobacco use after cancer diagnosis is associated with adverse cancer outcomes, yet reliable prevalence estimates for this behavior are lacking. We conducted a systematic literature review of the prevalence of current tobacco use among individuals with a history of lung or head/neck cancer (CRD #42012002625). An extensive search of electronic databases (MEDLINE, EMBASE, Cochrane Library, CINAHL, PsycINFO, and Web of Science) identified 7,777 potentially relevant articles published between 1980 and 2014 and 131 of these yielded pertinent information. Aggregating results across heterogeneous study designs and diverse patient samples, the overall mean prevalence rate of current tobacco use (mostly cigarette smoking) was 33.0% (median, 31.0%). Among current tobacco users at cancer diagnosis, the mean prevalence rate of current tobacco use (mostly cigarette smoking) was 53.8% (median, 50.3%). In many cases, an operational definition of "current" tobacco use was absent, and biochemical verification of self-reported smoking status was infrequent. These and other observed methodologic limitations in the assessment and reporting of cancer patients' tobacco use underscore the necessity of uniform tobacco use assessment in future clinical research and cancer care.
Lucille P. Markey Cancer Center, Cancer Prevention and Control Program, Lexington, Kentucky. University of Kentucky, Department of Psychology, Lexington, Kentucky. burris.jessica@gmail.com.
Jessica L
JL
Burris
Lucille P. Markey Cancer Center, Cancer Prevention and Control Program, Lexington, Kentucky. University of Kentucky, Department of Behavioral Science, Lexington, Kentucky.
Jamie L
JL
Studts
Memorial Sloan Kettering Cancer Center, Medical Library, New York, New York.
Antonio P
AP
DeRosa
Memorial Sloan Kettering Cancer Center, Psychiatry and Behavioral Sciences Service, New York, New York.
Jamie S
JS
Ostroff
D035843:Biomedical Research / Q000592:standards*; D014943:Global Health; D017408:Guidelines as Topic; D006258:Head and Neck Neoplasms / Q000175:diagnosis* / Q000209:etiology; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis* / Q000209:etiology; D009017:Morbidity / Q000639:trends; D012907:Smoking / Q000009:adverse effects / Q000453:epidemiology*; D015996:Survival Rate / Q000639:trends; D064424:Tobacco Use / Q000009:adverse effects / Q000453:epidemiology*